Endo 2006 - Events - Theratechnologies, TSX TH, Tesamorelin, Lipohypertrophy, Lipodystrophy treatment

Model and picture are being used for illustrative purposes only.

Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

NEWS AND EVENTS

From June 24 to 27, 2006

Endo 2006, Boston, United States

P3-773 Endocrine Effects of TH9507, a growth Hormone-Releasing Factor (GRF) Analogue, in Healthy Elderly subjects: Growth Hormone (GH) and Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3) Responses (PDF : 133.47 K)

P3-774 Effects of TH9507, a Growth Hormone-Releasing Factor (GRF) Analogue, on glucose parameters (PDF : 182.8 K)

Terms of use